Helmedix

About:

Helmedix is a biopharmaceutical company that develops therapeutic peptide drugs for autoimmune diseases.

Top Investors: Medical Research Commercialisation Fund (MRCF)

Description:

Helmedix Pty. Ltd. operates as a biopharmaceutical company which develops therapeutic peptide drugs for autoimmune diseases.

Total Funding Amount:

$1.29M

Headquarters Location:

Melbourne, Victoria, Australia

Founded Date:

2012-01-01

Founders:

John Dalton, Mark Robinson, Sheila Donnelly

Number of Employees:

1-10

Last Funding Date:

2013-02-18

IPO Status:

Private

Industries: